Zevra Therapeutics Inc. (ZVRA) made headlines yesterday with a landmark FDA approval for its innovative drug, MIPLYFFA, in the ...

Zevra Therapeutics Inc. (ZVRA) said that the U.S. Food and Drug Administration approved MIPLYFFA (MY-PLY-FAH) (arimoclomol) capsules ...

Mondelez International Inc. (MDLZ) said that it agreed to acquire a significant majority stake in Evirth, a manufacturer of cakes and ...

Qualcomm Inc. (QCOM) has recently approached Intel Corp. (INTC) regarding a possible takeover, the Wall Street Journal reported ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 ...

Analyst William Power of Robert W. Baird maintained a Hold rating on Confluent (CFLT – Research Report), retaining the price target of ...

AI solutions magnate Cerebral Blue has created NeuralSeek, a streamlined artificial intelligence platform that allows for ...

Kepler Capital analyst Filippo Prini maintained a Buy rating on Equita Group SpA (EQUI – Research Report) on September 19 and set a ...

In a report released on September 19, Thomas Neuhold from Kepler Capital maintained a Buy rating on Vonovia (0QFT – Research Report), ...

In a report released on September 19, Matthias Maenhaut from Kepler Capital maintained a Buy rating on Kinepolis Group NV (KPSN – ...

In a report released on September 19, Jon Berggren from Kepler Capital downgraded Swedish Orphan Biovitrum AB (0MTD – Research Report) ...

In a report released on September 19, Christian Faitz from Kepler Capital maintained a Buy rating on BASF SE (0BFA – Research Report), ...